• In this report, we forecast the epidemiology of actinic keratosis in the seven largest mature pharmaceutical markets (France, Germany, Italy, Japan, Spain, the United Kingdom and the United States) over the next 10 years
  • We forecast that the total number of prevalent cases of actinic keratosis in these seven mature markets will increase by 20% from 58 million to 69 million in 10 years.
  • The number of prevalent cases of actinic keratosis will increase across all these seven mature markets, despite age-adjusted disease risk remaining constant, due to demographic trends. The dominant factor determining the change in prevalent cases of actinic keratosis over the next 10 years will be population aging.

Testing is going on please ignore the dummy text added.

Table of contents

  • Tarannum Topic - Chapter One - Report One

Author(s): Alex Dirl